Certified by Founder Lodge
Phialogics - The immune tolerance company
Germany - Frankfurt, Hesse
START UP
1 Disclosed Funding Rounds $662,970
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for
Date | Round | Raised | Participating Investors |
---|---|---|---|
May, 08 ,2023 | Pre-Seed | $662,970 |